The safety and efficacy of Rivastigmine plus memantine versus Rivastigmine monotherapy in mild to moderate Alzheimer's disease

被引：0
|
作者：
Figiel, GS [1 ]
Figiel, S [1 ]
机构：
[1] Emory Eastside Heritage Ctr, Snellville, GA USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2006年 / 54卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
下载
收藏
页码：S186 / S187
页数：2
相关论文
共 50 条
  • [41] Rivastigmine in the pharmacotherapy of Alzheimer's disease
    Volz, HP
    Maurer, I
    PSYCHOPHARMAKOTHERAPIE, 2001, 8 (03): : 104 - 110
  • [42] Effects of Transdermal Rivastigmine on ADAS-Cog Items in Mild-to-Moderate Alzheimer's Disease
    Grossberg, George T.
    Schmitt, Frederick A.
    Meng, Xiangyi
    Tekin, Sibel
    Olin, Jason
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (08): : 627 - 633
  • [43] Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease
    Grossberg, G. T.
    Olin, J. T.
    Somogyi, M.
    Meng, X.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (04) : 465 - 471
  • [44] The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
    Loveman, E
    Green, C
    Kirby, J
    Takeda, A
    Picot, J
    Payne, E
    Clegg, A
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (01) : III - +
  • [45] Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's type
    Hossain, M
    Jhee, SS
    Shiovitz, T
    McDonald, C
    Sedek, G
    Pommier, F
    Cutler, NR
    CLINICAL PHARMACOKINETICS, 2002, 41 (03) : 225 - 234
  • [46] Estimation of the Absolute Bioavailability of Rivastigmine in Patients with Mild to Moderate Dementia of the Alzheimer’s Type
    Mohammad Hossain
    Stanford S. Jhee
    Thomas Shiovitz
    Craig McDonald
    Greg Sedek
    Francoise Pommier
    Neal R. Cutler
    Clinical Pharmacokinetics, 2002, 41 : 225 - 234
  • [47] A 24 week trial investigating the safety, tolerability and efficacy of rivastigmine in mild to moderately severe Alzheimer's disease patients in Korea
    Kim, SY
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S95 - S95
  • [48] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment for treatment of Alzheimer's disease
    Shua-Haim, JR
    Pass, M
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 356 - 356
  • [49] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease.
    Shua-Haim, JR
    Pass, MD
    Smith, J
    Lee, PP
    Patel, S
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S93 - S93
  • [50] Memantine monotherapy increases brain metabolism and effectively treats mild to moderate Alzheimer's disease
    Potkin, SG
    Alva, G
    McDonald, S
    Gergel, I
    Keator, DB
    Fallon, JH
    ANNALS OF NEUROLOGY, 2004, 56 : S48 - S49
12345